Canada · Series A startup

Who invested in BioRender

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Art & Design

Y Combinator: W18

Funding summaryUpdated 26 Oct 2026

$15Mraised across 1 round since 2023, from 1 source

Latest round
Series A, $15MApr 2023
Investors
4
See who backed them

The rounds

  1. Apr 2023

Founders and team

From BioRender's own website: 2 on the team.

  • Christoph RösliDirector of Research
  • Dr. Kevin ZwezdarykGrant Reviewer & Assistant Professor

Everyone who backed them

Y CombinatorAccelerator1round
Liquid 2 VenturesVC firm1round
FundersClubVC firm1round
Refactor CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list BioRender as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Fortius VenturesVC firmPer its own site
Olima VenturesVC firmPer its own site

Quick answers about BioRender

Who invested in BioRender?

BioRender's investors include Y Combinator, Liquid 2 Ventures, FundersClub and Refactor Capital.

How much has BioRender raised?

BioRender has raised $15M across 1 round since 2023.

When did BioRender last raise?

BioRender's most recent round was a Series A of $15M in Apr 2023.

What was BioRender's biggest round?

Its most recent round, $15M in Apr 2023, is also its largest on record.

Who backed BioRender first?

BioRender's first round on record, in Apr 2023, was backed by Y Combinator, Liquid 2 Ventures and FundersClub and 1 others.

What stage is BioRender at?

BioRender's latest named round is a Series A, in Apr 2023.

Where is BioRender based?

BioRender is based in Canada.

Companies like BioRender

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.